Latest for Halda Therapeutics

Our Team is Excited About the $3.05B Acquisition of Our Portfolio Company, Halda Therapeutics, by Johnson & Johnson
Highlight

Our Team is Excited About the $3.05B Acquisition of Our Portfolio Company, Halda Therapeutics, by Johnson & Johnson

Congrats From Canaan Partners! Canaan congratulates Canaan GP Tim Shannon, Canaan EIR Chris Schade, Halda Scientific founder Craig Crews, and the entire Halda team on the announcement of Halda's acquisition by Johnson & Johnson.